Home
Conditions
Neoplasms, Nerve Tissue

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,286 public trials 1,280 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Active, Not Recruiting

Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors

NCT01535911

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +14 more
Locations: Michigan State University/Sparrow Hospital East Lansing, Michigan, United States

View Trial Details

Active, Not Recruiting

A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma

NCT05418972

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Melanoma Institute Australia Wollstonecraft, New South Wales, Australia

View Trial Details

Active, Not Recruiting

Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

NCT03543969

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +13 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

NCT04459273

Conditions: Adenocarcinoma, Adrenal Gland Diseases, Adrenal Gland Neoplasms, +77 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma

NCT03389230

Conditions: Astrocytoma, Glioblastoma, Glioma, +11 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration

NCT04201457

Conditions: Glioma, High Grade Glioma (HGG) of the Brain With BRAF Aberration, Low Grade Glioma (LGG) of Brain With BRAF Aberration, +8 more
Locations: Phoenix Children's Hospital Phoenix, Arizona, United States

Children's Hospital Los Angeles Los Angeles, California, United States

Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States

Children's Hospital Colorado Aurora, Colorado, United States

View all 15 locations

View Trial Details

Active, Not Recruiting

Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life

NCT00639301

Conditions: Eye Diseases, Eye Diseases, Hereditary, Eye Neoplasms, +11 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy

NCT04645680

Conditions: Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Eye Diseases, +23 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Optimization of Immunotherapy Treatment for Advanced Melanoma in the Context of the Public Brazilian Health System (OTIMAS)

NCT07376317

Conditions: Cutaneous Melanoma, Melanoma, Melanoma Metastatic, +13 more
Locations: ICESP São Paulo, Brazil

View Trial Details

Active, Not Recruiting

UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade

NCT03474497

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +37 more
Locations: UC Davis Medical Center Sacramento, California, United States

University of California Davis Medical Center Sacramento, California, United States

View Trial Details

Neoplasms, Nerve Tissue

Neoplasms, Nerve Tissue trial results

Related conditions